Undervalued Small Caps With Insider Action In United Kingdom For September 2024

In This Article:

The United Kingdom market has been experiencing turbulence, with the FTSE 100 index closing lower amid weak trade data from China and broader global economic concerns. Despite these challenges, there are opportunities to be found in undervalued small-cap stocks, particularly those that have seen insider action, which can often signal confidence from within the company.

Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom

Name

PE

PS

Discount to Fair Value

Value Rating

Domino's Pizza Group

14.9x

1.7x

39.77%

★★★★★☆

Genus

158.0x

1.9x

3.84%

★★★★★☆

GB Group

NA

2.8x

36.77%

★★★★★☆

Bytes Technology Group

26.4x

6.0x

5.94%

★★★★☆☆

NWF Group

8.6x

0.1x

35.78%

★★★★☆☆

CVS Group

22.7x

1.3x

40.30%

★★★★☆☆

Essentra

700.7x

1.4x

39.49%

★★★★☆☆

Harworth Group

11.9x

6.2x

-588.15%

★★★☆☆☆

Oxford Instruments

23.1x

2.5x

-29.30%

★★★☆☆☆

Rank Group

31.6x

0.5x

38.65%

★★★☆☆☆

Click here to see the full list of 25 stocks from our Undervalued UK Small Caps With Insider Buying screener.

Underneath we present a selection of stocks filtered out by our screen.

Bytes Technology Group

Simply Wall St Value Rating: ★★★★☆☆

Overview: Bytes Technology Group is an IT solutions provider with a market cap of approximately £1.20 billion.

Operations: The company's revenue is primarily derived from its IT solutions segment, amounting to £207.02 million. For the period ending February 29, 2024, it reported a gross profit margin of 70.42% and a net income of £46.85 million with operating expenses at £89.07 million and non-operating expenses at £9.86 million

PE: 26.4x

Bytes Technology Group, a small-cap player in the UK, recently approved both a final dividend of 6.0 pence per share and a special dividend of 8.7 pence per share at their AGM on July 11, 2024. These dividends were paid out on August 2, reflecting strong financial health despite relying entirely on external borrowing for funding. Insider confidence is evident with significant share purchases over the past six months. Earnings are projected to grow by nearly 9% annually, suggesting potential for future value appreciation.

LSE:BYIT Share price vs Value as at Sep 2024
LSE:BYIT Share price vs Value as at Sep 2024

Genus

Simply Wall St Value Rating: ★★★★★☆

Overview: Genus is a biotechnology company specializing in animal genetics, with a market cap of approximately £2.50 billion.

Operations: Genus generates revenue primarily from its Genus ABS and Genus PIC segments, with significant contributions from both. The company has seen varying net income margins over the periods, with a notable trend of gross profit margin peaking at 68.02% in March 2024. Operating expenses and R&D costs are substantial components of its cost structure, impacting overall profitability.